Goldman Sachs’s Attovia Therapeutics ATTO Stock Holding History
Bought
Maintained
Sold
Other funds holding ATTO
Goldman Sachs's ATTO Position: Q3 2026 in Review
Goldman Sachs opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 5,391,772 shares worth $92.4M. The stake represents 0.01% of the portfolio and ranks #1186 among its holdings.
57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.
- Goldman Sachs held 5,391,772 shares of Attovia Therapeutics worth $92.4M as of Q3 2026.
- Attovia Therapeutics was a new Goldman Sachs position in Q3 2026.
- Attovia Therapeutics made up 0.01% of Goldman Sachs's portfolio in Q3 2026, its #1186 holding.
- 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.